615731650	615731650	CD	B-NP	O
|	|	NN	I-NP	O
RNAMC	RNAMC	NN	I-NP	O
|	|	NN	I-NP	O
09399642	09399642	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5992963	5992963	CD	B-NP	O
|	|	CC	I-NP	O
1/16/2005	1/16/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-cell_line
LINE	LINE	NNP	I-NP	I-cell_line
INFECTION	INFECTION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/1/2005	11/1/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/21/2005	3/21/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
JEUDY	JEUDY	NNP	B-NP	O
,	,	,	O	O
REX	REX	NNP	B-NP	B-protein
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Fevers	Fever	NNS	B-NP	O
,	,	,	O	O
pain	pain	VBP	B-VP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
Hickman	Hickman	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
41-year-old	41-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
aplastic	aplastic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
since	since	IN	B-PP	O
age	age	NN	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
hips	hip	NNS	I-NP	O
and	and	CC	I-NP	O
shoulders	shoulder	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
replacements	replacement	NNS	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
previous	previous	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
pain	pain	VB	B-VP	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	B-DNA
Hickman	Hickman	NNP	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Friday	Friday	NNP	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
sick	sick	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
all	all	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
knee	knee	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

That	That	DT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
present	present	JJ	B-ADJP	O
since	since	IN	B-PP	O
July	July	NNP	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
motor	motor	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	O	O
noticed	notice	VBD	B-VP	O
herself	herself	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
febrile	febrile	JJ	B-ADJP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
induration	induration	NN	I-NP	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	O
Hickman	Hickman	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
called	call	VBD	B-VP	O
her	her	PRP$	B-NP	O
physician	physician	NN	I-NP	O
who	who	WP	B-NP	O
told	tell	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
sputum	sputum	NN	B-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
nasal	nasal	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
rashes	rash	NNS	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
urinary	urinary	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
or	or	CC	I-NP	O
urgency	urgency	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
positivity	positivity	NN	I-NP	O
,	,	,	O	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
transfusion	transfusion	NN	B-NP	O
dependent	dependent	JJ	I-NP	O
,	,	,	I-NP	O
acute	acute	JJ	I-NP	B-protein
2	2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hips	hip	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacements	replacement	NNS	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
secondary	secondary	JJ	I-NP	O
hemachromatosis	hemachromatosis	NN	I-NP	O
and	and	CC	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
acetaminophen	acetaminophen	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	I-NP	O
units	unit	NNS	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Humalog	Humalog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
98	98	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
t.i.d.	t.i.d.	FW	I-NP	I-protein
p.r.n.	p.r.n.	FW	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
quinine	quinine	NN	B-NP	O
260	260	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Compazine	Compazine	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
noncontributory	noncontributory	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
Hickman	Hickman	NNP	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
and	and	CC	O	O
peripherally	peripherally	RB	B-NP	O
plain	plain	JJ	I-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
knee	knee	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lumbar	lumbar	NN	I-NP	O
spine	spine	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
97.8	97.8	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
80	80	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
102/68	102/68	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
16	16	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	NN	B-NP	O
and	and	CC	I-NP	O
alert	alert	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
moist	moist	NN	B-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
pinpoint	pinpoint	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
7	7	CD	B-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
,	,	,	O	O
carotid	carotid	NN	B-NP	O
upstrokes	upstroke	NNS	I-NP	O
were	be	VBD	B-VP	O
brisk	brisk	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
,	,	,	I-NP	O
murmurs	murmur	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
medial	medial	JJ	B-NP	O
knee	knee	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
49	49	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
complete	complete	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
735	735	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
26	26	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	B-protein
count	count	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
7	7	CD	B-NP	I-protein
.	.	.	O	O

Plain	Plain	NN	B-NP	O
films	film	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
knee	knee	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
sclerosis	sclerosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
femur	femur	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Plain	Plain	NN	B-NP	O
films	film	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
L-spine	L-spine	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
coag-negative	coag-negative	JJ	B-NP	O
staphylococcus	staphylococcus	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
Hickman	Hickman	NNP	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
and	and	CC	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
intravenously	intravenously	RB	B-ADVP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
2-week	2-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
hip	hip	NN	I-NP	O
and	and	CC	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
MVA	MVA	NN	I-NP	B-protein
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
likely	likely	RB	B-ADVP	O
exacerbated	exacerbate	VBD	B-VP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pain	pain	NN	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Anesthesia	Anesthesia	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
PCA	PCA	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
methadone	methadone	NN	B-NP	O
40	40	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
.	.	.	O	O

Toward	Toward	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
somnolent	somnolent	JJ	B-ADJP	O
,	,	,	O	O
perhaps	perhaps	RB	B-VP	O
over	over	RB	I-VP	O
sedated	sedate	VBN	I-VP	O
from	from	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
back	back	RB	B-ADVP	O
down	down	RB	I-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
versus	versus	IN	B-PP	O
the	the	DT	B-NP	O
methadone	methadone	NN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
oxycodone	oxycodone	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	CD	I-NP	O
p.	p.	NN	I-NP	O
r.n.	r.n.	NN	I-NP	O
,	,	,	O	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
blood	blood	NN	B-NP	O
for	for	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
25	25	CD	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
subclavian	subclavian	JJ	B-NP	O
clot	clot	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
Hickman	Hickman	NNP	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
study	study	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
transfuse	transfuse	VB	I-VP	O
platelets	platelet	NNS	B-NP	B-cell_type
only	only	RB	B-SBAR	O
if	if	IN	I-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
actively	actively	RB	I-VP	O
bleeding	bleed	VBG	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
having	have	VBG	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
hyper	hyper	NN	B-NP	O
and	and	CC	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
regimen	regimen	NN	I-NP	O
NPH	NPH	NN	I-NP	O
34	34	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
Humalog	Humalog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
office	office	NN	B-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
adjust	adjust	VB	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Synthroid	Synthroid	NN	I-NP	O
at	at	IN	B-PP	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
initially	initially	RB	B-ADVP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
system	system	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
pneumoboots	pneumoboot	NNS	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
had	have	VBD	I-VP	O
her	her	PRP$	B-NP	O
nutrition	nutrition	NN	I-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	I-NP	O
thiamine	thiamine	NN	I-NP	O
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
GI	GI	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
with	with	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Colace	Colace	NNP	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
stool	stool	NN	I-NP	O
softener	softener	NN	I-NP	O
versus	versus	IN	B-PP	O
her	her	PRP$	B-NP	O
narcotics	narcotic	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
neutropenia	neutropenia	NN	B-NP	O
and	and	CC	O	O
Hickman	Hickman	NNP	B-NP	O
line	line	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
coag-negative	coag-negative	JJ	B-NP	O
staphylococcus	staphylococcus	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
ended	end	VBD	B-VP	O
on	on	IN	B-PP	O
6/5/05	6/5/05	CD	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
placed	place	VBN	B-VP	O
by	by	IN	B-PP	O
general	general	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
procedure	procedure	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
separate	separate	JJ	B-NP	O
operative	operative	JJ	I-NP	O
report	report	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Biagioni	Biagioni	NNP	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
methadone	methadone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
quinine	quinine	NN	B-NP	O
260	260	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
baclofen	baclofen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
35	35	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
11/19/06	11/19/06	CD	B-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
American	American	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
association	association	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
,	,	,	O	O
improved	improve	VBN	B-VP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-3187475	3-3187475	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
KAMPMANN	KAMPMANN	NNP	B-NP	O
,	,	,	O	O
LOREN	LOREN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCHWIESOW	SCHWIESOW	NNP	B-NP	O
,	,	,	O	O
JEFF	JEFF	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2136430	2136430	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/20/07	8/20/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/20/07	8/20/07	CD	B-NP	O

